Memorial Sloan Kettering Curbs Executives’ Ties to Industry After Conflict-of-Interest Scandals

The cancer center will now bar top officials from sitting on outside boards of for-profit companies, and is conducting a wide-scale review of other policies. KATIE THOMAS and CHARLES ORNSTEIN https://nyti.ms/2RpLXYc http://bit.ly/2HaaPyl The New York Times Health Boards of Directors, Drugs (Pharmaceuticals) January 11, 2019 at 12:00AM